Two proteins involved in the cellular uptake of cobalamin: transcobalamin II (TCII) and transcobalamin II receptor (TCblR/CD320) have been explored as potential tumor biomarkers as their expression is elevated in cancer cells [5,7]. The gene discussed is CD320; the disease is neoplasm.